Vulnerability Description
cfgcon in IBM AIX 5.2 and 5.3 does not properly validate the argument to the "-p" option to swcons, which allows local users in the system group to create an arbitrary file, and enable world writability of this file, via a symlink attack involving use of the file's name as the argument. NOTE: this issue is due to an incomplete fix for CVE-2007-5804.
CVSS Score
MEDIUM
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Ibm | Aix | 5.2 |
Related Weaknesses (CWE)
References
- ftp://aix.software.ibm.com/aix/efixes/security/cfgcon_ifix.tarPatch
- http://labs.idefense.com/intelligence/vulnerabilities/display.php?id=611
- http://secunia.com/advisories/27437
- http://www-1.ibm.com/support/docview.wss?uid=isg1IZ03055
- http://www-1.ibm.com/support/docview.wss?uid=isg1IZ03061
- http://www.securityfocus.com/bid/26258Patch
- http://www14.software.ibm.com/webapp/set2/subscriptions/ijhifoeblist?mode=7&headPatch
- https://exchange.xforce.ibmcloud.com/vulnerabilities/38154
- ftp://aix.software.ibm.com/aix/efixes/security/cfgcon_ifix.tarPatch
- http://labs.idefense.com/intelligence/vulnerabilities/display.php?id=611
- http://secunia.com/advisories/27437
- http://www-1.ibm.com/support/docview.wss?uid=isg1IZ03055
- http://www-1.ibm.com/support/docview.wss?uid=isg1IZ03061
- http://www.securityfocus.com/bid/26258Patch
- http://www14.software.ibm.com/webapp/set2/subscriptions/ijhifoeblist?mode=7&headPatch
FAQ
What is CVE-2007-5805?
CVE-2007-5805 is a vulnerability with a CVSS score of 6.9 (MEDIUM). cfgcon in IBM AIX 5.2 and 5.3 does not properly validate the argument to the "-p" option to swcons, which allows local users in the system group to create an arbitrary file, and enable world writabili...
How severe is CVE-2007-5805?
CVE-2007-5805 has been rated MEDIUM with a CVSS base score of 6.9/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2007-5805?
Check the references section above for vendor advisories and patch information. Affected products include: Ibm Aix.